Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast

BMJ. 2000 May 27;320(7247):1474-5; author reply 1475-6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adjuvants, Immunologic / economics
  • Adjuvants, Immunologic / therapeutic use*
  • Drug Costs
  • Humans
  • Interferon beta-1a
  • Interferon beta-1b
  • Interferon-beta / economics
  • Interferon-beta / therapeutic use*
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / economics

Substances

  • Adjuvants, Immunologic
  • Interferon beta-1b
  • Interferon-beta
  • Interferon beta-1a